**RFK Jr. remains firmly in place as HHS Secretary through the final months of 2026, with recent leadership reorganizations and policy implementation reinforcing expectations he will stay through December 31.** As of late August 2026, the department under his direction has expanded non-Senate-confirmed political appointees to the highest level in decades, advanced workforce reductions aligned with administration efficiency goals, and continued MAHA initiatives on nutrition, chronic disease, and regulatory oversight. President Trump has maintained public support, hosting Kennedy at the White House and endorsing his role in health policy. No official statements, Senate actions, or credible reporting indicate plans for resignation or removal, and Kennedy has explicitly ruled out a 2028 presidential run that might prompt an exit. Trader consensus at 74% for “No” reflects this stability, as structural alignment with the administration and absence of triggering events outweigh calls for his departure from outside critics. Scheduled budget testimony and ongoing agency priorities through year-end further anchor the current positioning.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour$24,303 Vol.
$24,303 Vol.
$24,303 Vol.
$24,303 Vol.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Marché ouvert : Mar 19, 2026, 2:02 PM ET
Résolveur
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Résolveur
0x65070BE91...**RFK Jr. remains firmly in place as HHS Secretary through the final months of 2026, with recent leadership reorganizations and policy implementation reinforcing expectations he will stay through December 31.** As of late August 2026, the department under his direction has expanded non-Senate-confirmed political appointees to the highest level in decades, advanced workforce reductions aligned with administration efficiency goals, and continued MAHA initiatives on nutrition, chronic disease, and regulatory oversight. President Trump has maintained public support, hosting Kennedy at the White House and endorsing his role in health policy. No official statements, Senate actions, or credible reporting indicate plans for resignation or removal, and Kennedy has explicitly ruled out a 2028 presidential run that might prompt an exit. Trader consensus at 74% for “No” reflects this stability, as structural alignment with the administration and absence of triggering events outweigh calls for his departure from outside critics. Scheduled budget testimony and ongoing agency priorities through year-end further anchor the current positioning.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour



Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes